Resolvins and inflammatory pain

F1000 Medicine Reports

Volumn 3, Issue 1, 2011, Pages

  Sommer, Claudia ^a   Birklein, Frank ^b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANTIINFLAMMATORY AGENT; CAPSAICIN; CARRAGEENAN; CD59 ANTIGEN; DOCOSAHEXAENOIC ACID; FORMALDEHYDE; FREUND ADJUVANT; LIPOXIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; OMEGA 3 FATTY ACID; RVD1; RVE1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANALGESIA; HOMEOSTASIS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; NONHUMAN; PAIN; PERIODONTITIS; REVIEW; SOFT TISSUE INFLAMMATION; STROKE; WOUND HEALING;

EID: 80053468385     PISSN: None     EISSN: 17575931     Source Type: Journal    
DOI: 10.3410/M3-19     Document Type: Review

References (28)

1. Serhan CN: Novel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not? Am J Pathol 2010, 177:1576-91. F1000 Factor 6 Evaluated by Claudia Sommer 20 Sep 2011
2. Serhan CN, Hong S, Gronert K, Colgan SP, Devchand PR, Mirick G, Moussignac RL: Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J Exp Med 2002, 196:1025-37. F1000 Factor 6 Evaluated by Claudia Sommer 20 Sep 2011
3. Anderson P, Delgado M: Endogenous anti-inflammatory neuropeptides and pro-resolving lipid mediators: a new therapeuticapproach for immune disorders. J Cell Mol Med 2008, 12:1830-47. F1000 Factor 6 Evaluated by Claudia Sommer 20 Sep 2011
4. Norling LV, Serhan CN: Profiling in resolving inflammatory exudates identifies novel anti-inflammatory and pro-resolving mediators and signals for termination. J Intern Med 2010, 268:15-24. F1000 Factor 6 Evaluated by Claudia Sommer 20 Sep 2011
5. Serhan CN: Systems approach to inflammation resolution: identification of novel anti-inflammatory and pro-resolving mediators. J Thromb Haemost 2009, 7(Suppl 1):44-8. F1000 Factor 6 Evaluated by Claudia Sommer 20 Sep 2011
6. Wall R, Ross RP, Fitzgerald GF, Stanton C: Fatty acids from fish: the anti-inflammatory potential of long-chain omega-3 fatty acids. Nutr Rev 2010, 68:280-9. F1000 Factor 6 Evaluated by Claudia Sommer 20 Sep 2011
7. Hasturk H, Kantarci A, Ohira T, Arita M, Ebrahimi N, Chiang N, Petasis NA, Levy BD, Serhan CN, van Dyke TE: RvE1 protects from local inflammation and osteoclast-mediated bone destruction in periodontitis. FASEB J 2006, 20:401-3. F1000 Factor 6 Evaluated by Claudia Sommer 20 Sep 2011
8. Dartt DA, Hodges RR, Li D, Shatos MA, Lashkari K, Serhan CN: Conjunctival goblet cell secretion stimulated by leukotrienes is reduced by resolvins d1 and e1 to promote resolution of inflammation. J Immunol 2011, 186:4455-66. F1000 Factor 6 Evaluated by Claudia Sommer 20 Sep 2011
9. ClinicalTrails.gov: Safety and Efficacy Study of RX-10045 on the Signs and Symptoms of Dry Eye. [http://www.clinicaltrials. gov/ct2/show/NCT00799552? term=resolvin&rank=2]
10. Xu ZZ, Zhang L, Liu T, Park JY, Berta T, Yang R, Serhan CN, Ji RR: Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions. Nat Med 2010, 16:592-7. F1000 Factor 14 Evaluated by Theodore Cummins 15 Jun 2010, Bruce Levy 16 Aug 2010, Claudia Sommer 20 Sep 2011
11. Ji RR, Gereau RWt, Malcangio M, Strichartz GR: MAP kinase and pain. Brain Res Rev 2009, 60:135-48. F1000 Factor 6 Evaluated by Claudia Sommer 20 Sep 2011
12. Ma W, Quirion R: The ERK/MAPK pathway, as a target for the treatment of neuropathic pain. Expert Opin Ther Targets 2005, 9:699-713. F1000 Factor 6 Evaluated by Claudia Sommer 20 Sep 2011
13. Huang L, Wang CF, Serhan CN, Strichartz G: Enduring prevention and transient reduction of postoperative pain by intrathecal resolvin D1. Pain 2011, 152:557-65. F1000 Factor 7 Evaluated by Stuart Bevan 19 Apr 2011, Claudia Sommer 20 Sep 2011
14. Lima-Garcia J, Dutra R, Da Silva K, Motta E, Campos M, Calixto J: The precursor of resolvin D series and aspirin-triggered resolvin D1 display anti-hyperalgesic properties in adjuvant-induced arthritis in rats. Br J Pharmacol 2011, 164:278-93. F1000 Factor 6 Evaluated by Claudia Sommer 20 Sep 2011
15. Bang S, Yoo S, Yang TJ, Cho H, Kim YG, Hwang SW: Resolvin D1 attenuates activation of sensory transient receptor potential channels leading to multiple anti-nociception. Br J Pharmacol 2010, 161:707-20. F1000 Factor 6 Evaluated by Claudia Sommer 20 Sep 2011
16. Ko GD, Nowacki NB, Arseneau L, Eitel M, Hum A: Omega-3 fatty acids for neuropathic pain: case series. Clin J Pain 2010, 26:168-72. F1000 Factor 6 Evaluated by Claudia Sommer 20 Sep 2011
17. Goldberg RJ, Katz J: A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain. Pain 2007, 129:210-23. F1000 Factor 6 Evaluated by Claudia Sommer 20 Sep 2011
18. Bang S, Yoo S, Yang T, Cho H, Hwang S: 17(R)-resolvin D1 specifically inhibits TRPV3 leading to peripheral antinociception. Br J Pharmacol 2011, [Epub ahead of print]. F1000 Factor 6 Evaluated by Claudia Sommer 20 Sep 2011
19. Nixon R, Bansback N, Brennan A: The efficacy of inhibiting tumour necrosis factor alpha and interleukin 1 in patients with rheumatoid arthritis: a meta-analysis and adjusted indirect comparisons. Rheumatology (Oxford) 2007, 46:1140-7. F1000 Factor 6 Evaluated by Claudia Sommer 20 Sep 2011
20. Bischofs S, Zelenka M, Sommer C: Evaluation of topiramate as an anti-hyperalgesic and neuroprotective agent in the peripheral nervous system. J Peripher Nerv Syst 2004, 9:70-8. (Pubitemid 38669199)
21. Geis C, Beyreuther BK, Stohr T, Sommer C: Lacosamide has protective disease modifying properties in experimental vincristine neuropathy. Neuropharmacology 2011, 61:600-7.
22. Birklein F, Kingery WS: Complex regional pain syndrome: A loss of inhibition? Pain 2009, 142:177-8.
23. Beyreuther BK, Geis C, Stöhr T, Sommer C: Antihyperalgesic efficacy of lacosamide in a rat model for muscle pain induced by TNF. Neuropharmacology 2007, 52:1312-7. (Pubitemid 46527705)
24. Ziegler D, Hidvegi T, Gurieva I, Bongardt S, Freynhagen R, Sen D, Sommerville K: Efficacy and Safety of Lacosamide in Painful Diabetic Neuropathy. Diabetes Care 2010, 33:839-41. F1000 Factor 6 Evaluated by Claudia Sommer 20 Sep 2011
25. Üçeyler N, Valenza R, Stock M, Schedel R, Sprotte G, Sommer C: Reduced levels of antiinflammatory cytokines in patients with chronic widespread pain. Arthritis Rheum 2006, 54:2656-64. (Pubitemid 44205028)
26. Parish RC, Evans JD: Inflammation in chronic heart failure. Ann Pharmacother 2008, 42:1002-16.
27. Giunta B, Fernandez F, Nikolic WV, Obregon D, Rrapo E, Town T, Tan J: Inflammaging as a prodrome to Alzheimer's disease. J Neuroinflammation 2008, 5:51.
28. Schwab JM, Serhan CN: Lipoxins and new lipid mediators in the resolution of inflammation. Curr Opin Pharmacol 2006, 6:414-20.